Replies to post #66479 on Biotech Values

[DewDiligence]

Thanks, Tinker. Any comments on the question in #msg-32320771 (How big is the CIS market?)? T.i.a. Dew

[masterlongevity]

"Presently, backing out the EDT business, tysabri is valued at ~$3.5 billion, and the alzheimer program, which is extensive, with many mid to late stage programs that are industry leading, is given what looks like $0 value, perhaps negative value."

IMHO tysabri and EDT should account for 90% of elan's valuation. they have yet to produce any positive clinical data from any of their alzheimer's programs. and as far as i can tell, they have noting else in their pipeline.

[DewDiligence]

ELN reiterated on Monday’s Natixis webcast that there will be no near-term sale of the EDT division.